Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lansoprazole ineffective for functional dyspepsia.

Anne L Mounsey1

  • 1Department of Family Medicine, University of Virginia Health Care System, Charlottesville, USA. alm2d@virginia.edu

The Journal of Family Practice
|January 24, 2003
PubMed
Summary

Proton pump inhibitors like lansoprazole offer no proven benefit for functional dyspepsia beyond a placebo effect. Less expensive antacids and H2 blockers are recommended alternatives for managing this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alternative Interventions for Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Men.

American family physician·2019
Same author

Cerebrospinal Fluid Biomarkers for Detection of Alzheimer Disease in Patients with Mild Cognitive Impairment.

American family physician·2018
Same author

Topical Antihistamines and Mast Cell Stabilizers for Treating Allergic Conjunctivitis.

American family physician·2016
Same author

Hepatitis C for primary care physicians.

Journal of the American Board of Family Medicine : JABFM·2014
Same author

FPIN's Clinical Inquiries. Treatment of motion sickness.

American family physician·2012
Same author

More help for patients with less severe heart failure.

The Journal of family practice·2011

Area of Science:

  • Gastroenterology
  • Pharmacology

Background:

  • Functional dyspepsia (FD) is characterized by persistent upper abdominal symptoms without identifiable organic causes or gastroesophageal reflux.
  • Proton pump inhibitors (PPIs) are commonly prescribed, but their efficacy in FD remains debated.

Discussion:

  • Evidence suggests that lansoprazole, a common PPI, does not provide specific therapeutic benefits for patients with functional dyspepsia.
  • Observed improvements in patients with FD treated with PPIs are likely attributable to the placebo effect, not pharmacological action.

Key Insights:

  • PPIs, including lansoprazole, are not recommended for functional dyspepsia due to lack of efficacy beyond placebo.
  • The use of PPIs for FD inflates healthcare costs without providing genuine clinical benefit.

Outlook:

  • Future research should focus on identifying effective treatments for functional dyspepsia that target underlying mechanisms.
  • Healthcare providers should consider cost-effective alternatives such as antacids and H2 blockers for managing FD symptoms.

Related Experiment Videos